N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid

Intensive Care Medicine

Volumn 22, Issue 9, 1996, Pages 900-908

  De Backer, W A ^a   Amsel, B ^a   Jorens, P G ^a   Bossaert, L ^a   Hiemstra, P S ^b   Van Noort, P ^b   Van Overveld, F J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiopulmonary bypass (CPB); Elastase; Myeloperoxidase; N acetylcysteine (NAC); Neutrophil

Indexed keywords

ACETYLCYSTEINE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; OXYGEN;

ADULT; AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL; OXYGENATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029796747     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02044114     Document Type: Article

References (46)

1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifido AD (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86: 845-847
2. Faymonville ME, Pincemail J, Duchateau J, Paulus JM, Adam A, Deby-Dupont G, Deby C, Albert A, Larbuisson R, Limet R, Lamy M (1991) Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 102: 309-317
3. Lambert CJ, Marengo-Rowe AJ, Leveson JE, Green RH, Thiele JP, Geisler GF, Adam M, Mitchel BF (1979) The treatment of post-perfusion bleeding using epsilon-aminocaproic acid, cytoprecipitate, fresh frozen plasma, and protamine sulphate. Ann Thorac Surg 28: 440-444
4. Stibbe J, Kluft C, Brommer E, Gomez M, De Jong D, Nauta J (1984) Enhanced fibinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 14: 375-382
5. De Backer WA, Verpooten G, Borgonjon D, Vermeire PA, De Broe M (1986) Hypoxemia during hemodialysis: effect of different membranes and dialysate compositions. Kidney Int 23: 738-743
6. Tennenberg SD, Bailey WW, Cotta LA, Brodt JK, Solomkin JS (1986) The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. Surgery 100: 134-141
7. Ward PA, Hill JH (1970) C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 104: 535-543
8. Antonsen S, Brandslund I, Clemensen S, Sofeldt S, Madsen T, Alstrup P (1987) Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 21: 47-52
9. Johnson KJ, Ward PA (1974) Acute immunologic pulmonary alveolitis. J Clin Invest 54: 349-357
10. Anderson BO, Brown JM, Bensard DD, Grosso MA, Banerjee A, Patt A, Whitman GJR, Harken AH (1990) Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanisms. Surgery 108: 262-268
11. Jorens PG, Van Damme J, De Backer WA, Bossaert L, De Jongh R, Herman A, Rampart M (1992) Interleukin-8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine 4: 592-597
12. Jorens PG, De Jongh RF, De Backer WA, Van Damme J, Bossaert L, Walter P, Herman A, van Overveld F, Rampart M (1993) Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am J Respir Crit Care Med 148: 890-895
13. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM (1983) Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 98: 593-597
14. Janoff A, Scherer J (1968) Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med 128: 1137-1155
15. 1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun 88: 402-409
16. 1-protease inhibitor by human neutrophils. J Biol Chem 256: 3348-3353
17. Moldeus P, Cotgreave IA, Berggren M (1986) Lung protection by a thiol-containing antioxidant N-acetylcysteine. Respiration 50: 31-42
18. Bernard GR (1991) N-Acetylcysteine in experimental and clinical lung injury. Am J Med 91: 54S-59S
19. Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593-597
20. Eklund A, Eriksson Ö, Håkansson L, Larsson K, Ohlson K, Venge P, Bergstrand H, Björnson A, Brattsand R, Glennow C, Linden M, Wieslander E (1988) Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers correlation to effects on cellular variables. Eur Respir J 1: 832-838
21. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT (1989) The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol over-dosage. Eur J Clin Pharmacol 37: 501-506
22. Coremans IE, Hagen EC, Daha MR, van der Woude FJ, van der Voort EA, Kleijburg-van der Keur C, Breedveld FC (1992) Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 35: 1466-1475
23. Feinstein G, Janoff A (1975) A rapid method of purification of human granulocyte cationic neutral proteases: purification and further characterisation of human granulocyte elastase. Biochim Biophys Acta 403: 493-505
24. Brower MS, Harpel PC (1983) Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes. Blood 5: 842-849
25. 1-proteinase inhibitor. J Clin Chem Clin Biochem 22: 693-697
26. Jorens PG, Richman-Eisenstat J, Housset B, Graf PD, Ueki IF, Olesch J, Nadel JA (1992) Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. Am J Physiol 263: L708-L713
27. Castillo MJ, Nakajima K, Zimmerman M, Powers JC (1979) Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays of serine proteases. Anal Biochem 99: 53-64
28. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61: 882-890
29. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Martin PG, Crystal RG (1986) Estimation of the absolute volume of epithelial lining fluid recovered by bronchoalveolar lavage using urea as an endogenous marker of dilution. J Appl Physiol 60: 532-538
30. Butler J, Pillai R, Rocker GM, Westaby MS, Parker D, Shale DJ (1993) Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 105: 25-30
31. Riegel W, Spillner G, Schlosser V, Hörl WH (1988) Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 95: 1014-1019
32. 2-macroglobulin with neutrophil and plasma proteinases. Ann NY Acad Sci 421: 316-326
33. 2-macroglobulin. J Clin Invest 82: 1260-1267
34. 1-antichymotrypsin. In: Havemann K, Janoff A (eds) Neutral proteases of human polymorphonuclear leukocytes. Urban and Schwarzenberg, Baltimore, pp 167-177
35. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304: 192-196
36. McGuire WW, Spragg RG, Cohen AB, Cochrane CG (1982) Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 69: 543-553
37. 1-proteinase inhibitor by N-acetylcysteine, glutathione and methionine. Agents Actions 22: 257-260
38. Weiss SJ, Curnutte JT, Regiani S (1986) Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Immunol 136: 636-641
39. Andersen LW, Thiis J, Kharazmi A, Rygg I (1995) The role of N-acetylcysteine administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 10: 21-26
40. Huupponen MR, Makinen LH, Hyvonen PM, Sen CK, Rankinen T, Vaisanen S, Rauramaa R (1995) The effect of N-acetylcysteine on exercise-induced priming of human neutrophils. A chemiluminescence study. Int J Sports Med 16: 399-403
41. Menasche P, Grousset C, Gauduel Y, Mouas C, Piwnica A (1992) Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection. J Thorac Cardiovasc Surg 103: 936-944
42. Hoffer E, Avidor I, Benjaminov O, Shenker L, Tabak A, Tamir A, Merzbach D, Taitelman T (1993) N-acetylcysteine delays the infiltration of inflammatory cells into the lungs of paraquat-intoxicated rats. Toxicol Appl Pharmacol 120: 8-12
43. Linden M, Wieslander E, Eklund A, Larsson K, Brattsand R (1988) Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers. Eur Respir J 1: 645-650
44. Holden EP, Blackwell TS, Blackwell TR, Bernard GR, Christman JW (1994) N-acetylcysteine attenuates nuclear factor KB activity in endotoxin-stimulated THP-1 cells: a mechanism for the transcriptional regulation of interleukin-8. Am J Respir Crit Care Med 149: A716
45. Suter P, Domenighetti G, Schaller MD, Laverrière MC, Ritz R, Perret C (1994) N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest 105: 190-194
46. Bernard GR, Artigas A, Brigham KL, Coulet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R, and the Consensus Committee (1994) The American European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824